The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non‐small‐cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method
Open accessAbstract
Comparison of the efficacy of different enrichment methods for detection of circulating tumor cells (CTCs) before radical surgery is lacking in non‐small‐cell lung carcinoma (NSCLC) patients. Detection and enumeration of CTCs in 210 consecutive patients undergoing radical surgery for NSCLC were evaluated with the CellSearch Assay™ (CS), using the CellSearch Epithelial Cell Kit, and by the isolation by size of epithelial tumor (ISET) method, using double immunolabeling with anti‐cytokeratin and anti‐vimentin antibodies. CTCs were detected in 144 of 210 (69%) patients using CS and/or ISET and in 104 of 210 (50%) and 82 of 210 (39%) patients using ISET and CS, respectively. Using ISET, 23 of 210 (11%) patients had vimentin‐positive cells with cytological criteria of malignancy. Disease‐free survival (DFS) was worse for patients with CTCs compared to patients without CTCs detected by CS alone (p < 0.0001; log rank = 30.59) or by ISET alone (p < 0.0001; log rank = 33.07). The presence of CTCs detected by both CS and ISET correlated even better with shorter DFS at a univariate (p < 0.0001; log rank = 42.15) and multivariate level (HR, 1.235; 95% CI, 1.056–1.482; p < 0.001). CS and ISET are complementary methods for detection of CTCs in preoperative radical surgery for NSCLC. CTC detection in resectable NSCLC patients using CS and/or ISET could be a prognostic biomarker of great interest and may open up new avenues into improved therapeutic strategies for lung carcinoma patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Revisions in the International System for Staging Lung Cancer
Mountain, C. F. (1997) · Chest · doi:10.1378/chest.111.6.1710 · Cited by 4,565
A note on quantifying follow-up in studies of failure time
Schemper, M., & Smith, T. L. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(96)00075-x · Cited by 2,575
Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0378 · Cited by 2,542 · cited 7×
“The v2 analysis was used to evaluate whether CTCs detected by ISET correlated with CTCs detected by CS.”
BackgroundResultInfluentialDetection of Mutations in EGFR in Circulating Lung-Cancer Cells
Maheswaran, S., Sequist, L. V., Nagrath, S., Ulkus, L., Brannigan, B., Collura, C. V., Inserra, E., Diederichs, S., Iafrate, A. J., Bell, D. W., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800668 · Cited by 1,617
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
Cristofanilli, M., Hayes, D. F., Budd, G. T., Ellis, M. J., Stopeck, A., Reuben, J. M., Doyle, G. V., Matera, J., Allard, W. J., Miller, M. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.140 · Cited by 1,135
Detection, clinical relevance and specific biological properties of disseminating tumour cells
Pantel, K., Brakenhoff, R. H., & Brandt, B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2375 · Cited by 1,118
Isolation by Size of Epithelial Tumor Cells
Vona, G., Sabile, A., Louha, M., Sitruk, V., Romana, S., Schütze, K., Capron, F., Franco, D., Pazzagli, M., Vekemans, M., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64706-2 · Cited by 1,069
Circulating tumor cells (CTC) detection: Clinical impact and future directions
Paterlini-Brechot, P., & Benali, N. L. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.014 · Cited by 947
Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer
Sozzi, G., Conte, D., Leon, M., Cirincione, R., Roz, L., Ratcliffe, C., Roz, E., Cirenei, N., Bellomi, M., Pelosi, G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.006 · Cited by 552
Sieuwerts, A. M., Kraan, J., Bolt, J., van der Spoel, P., Elstrodt, F., Schutte, M., Martens, J. W. M., Gratama, J.-W., Sleijfer, S., & Foekens, J. A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn419 · Cited by 435
Resting and activated endothelial cells are increased in the peripheral blood of cancer patients
Mancuso, P., Burlini, A., Pruneri, G., Goldhirsch, A., Martinelli, G., & Bertolini, F. (2001) · Blood · doi:10.1182/blood.v97.11.3658 · Cited by 421
Rao, C., Chianese, D., Doyle, G., Miller, M., Russell, T., Sanders, R., & Terstappen, L. (2005) · International Journal of Oncology · doi:10.3892/ijo.27.1.49 · Cited by 327
van Rens, M. T. M., van den Bosch, J. M. M., Brutel de la Rivière, A., & Elbers, H. R. J. (2000) · Chest · doi:10.1378/chest.117.2.374 · Cited by 273
Circulating Tumor Cells and Bone Marrow Micrometastasis
Alix-Panabières, C., Riethdorf, S., & Pantel, K. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5125 · Cited by 244
Naruke, T., Tsuchiya, R., Kondo, H., & Asamura, H. (2001) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(00)02609-6 · Cited by 241
Hou, J.-M., Greystoke, A., Lancashire, L., Cummings, J., Ward, T., Board, R., Amir, E., Hughes, S., Krebs, M., Hughes, A., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090078 · Cited by 238
Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer
Vona, G., Estepa, L., Béroud, C., Damotte, D., Capron, F., Nalpas, B., Mineur, A., Franco, D., Lacour, B., Pol, S., et al. (2004) · Hepatology · doi:10.1002/hep.20091 · Cited by 215
Pinzani, P., Salvadori, B., Simi, L., Bianchi, S., Distante, V., Cataliotti, L., Pazzagli, M., & Orlando, C. (2006) · Human Pathology · doi:10.1016/j.humpath.2006.01.026 · Cited by 160
Lu, J. M., Fan, T. M., Zhao, Q., Zeng, W., Zaslavsky, E., Chen, J. J.-W., Frohman, M. A., Golightly, M. G., Madajewicz, S., & Chen, W. (2009) · International Journal of Cancer · doi:10.1002/ijc.24814 · Cited by 149
Peck, K., Sher, Y., Shih, J. Y., Roffler, S. R., Wu, C. W., & Yang, P. (1998) · PubMed · Cited by 135
Saito, R.-A., Watabe, T., Horiguchi, K., Kohyama, T., Saitoh, M., Nagase, T., & Miyazono, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3490 · Cited by 134
Blanchon, F., Grivaux, M., Asselain, B. J. R., Lebas, F.-X., Orlando, J.-P., Piquet, J., & Zureik, M. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70868-3 · Cited by 126
Rolle, A., Günzel, R., Pachmann, U. A., Willen, B., Höffken, K., & Pachmann, K. (2005) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-3-18 · Cited by 118
Pfannschmidt, J., Muley, T., Bülzebruck, H., Hoffmann, H., & Dienemann, H. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.10.017 · Cited by 110
Sher, Y., Shih, J., Yang, P., Roffler, S. R., Chu, Y.-W., Wu, C., Yu, C.-L., & Peck, K. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.173.11.1 · Cited by 107
Wu, C., Hao, H., Li, L., Zhou, X., Guo, Z., Zhang, L., Zhang, X., Zhong, W., Guo, H., Bremner, R. M., et al. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181914125 · Cited by 103
Circulating Tumor Cells in Pulmonary Venous Blood of Primary Lung Cancer Patients
Okumura, Y., Tanaka, F., Yoneda, K., Hashimoto, M., Takuwa, T., Kondo, N., & Hasegawa, S. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2009.03.073 · Cited by 100
Prognostic Significance of Micrometastasis in Non–Small-Cell Lung Cancer
Coello, M. C., Luketich, J. D., Litle, V. R., & Godfrey, T. E. (2004) · Clinical Lung Cancer · doi:10.3816/clc.2004.n.002 · Cited by 95
Circulating endothelial cells in oncology: pitfalls and promises
Strijbos, M. H., Gratama, J. W., Kraan, J., Lamers, C. H., den Bakker, M., & Sleijfer, S. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604383 · Cited by 91
Sawabata, N., Okumura, M., Utsumi, T., Inoue, M., Shiono, H., Minami, M., Nishida, T., & Sawa, Y. (2007) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-007-0101-2 · Cited by 88
Katz, R. L., He, W., Khanna, A., Fernandez, R. L., Zaidi, T. M., Krebs, M., Caraway, N. P., Zhang, H.-Z., Jiang, F., Spitz, M. R., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3358 · Cited by 64
Sheu, C., Yu, Y., Tsai, J., Chang, M., Lin, S., Hwang, J., & Chong, I. (2006) · International Journal of Cancer · doi:10.1002/ijc.21999 · Cited by 39
Biggers, B., Knox, S. M., Grant, M., Kuhn, J. G., Nemunatitis, J., Fisher, T. L., & Lamont, J. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0314-y · Cited by 33
Cited by
Liquid Biopsy: From Discovery to Clinical Application
Alix-Panabières, C., & Pantel, K. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1311 · Cited by 953
Progress and prospects of early detection in lung cancer
Blandin Knight, S., Crosbie, P. A., Balata, H., Chudziak, J., Hussell, T., & Dive, C. (2017) · Open Biology · doi:10.1098/rsob.170070 · Cited by 935
Review of precision cancer medicine: Evolution of the treatment paradigm
Tsimberidou, A. M., Fountzilas, E., Nikanjam, M., & Kurzrock, R. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102019 · Cited by 756
Circulating tumor cell technologies
Ferreira, M. M., Ramani, V. C., & Jeffrey, S. S. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.01.007 · Cited by 511
Circulating Tumor Cells and Circulating Tumor DNA
Alix-Panabières, C., Schwarzenbach, H., & Pantel, K. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-062310-094219 · Cited by 485
Metadata
- Authors
- Hofman, V., Ilie, M. I., Long, E., Selva, E., Bonnetaud, C., Molina, T., Vénissac, N., Mouroux, J., Vielh, P., & Hofman, P.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2011-03-11
- Volume
- 129
- Issue
- 7
- Pages
- 1651-1660
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2041353834
- Cited by
- 304
- References
- 33
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.